The Blood Group Typing Market is gaining importance as healthcare systems strengthen laboratory testing procedures associated with blood transfusion and transplantation. Accurate identification of ABO and Rh blood groups helps support compatible transfusion practices, while advanced typing methods can provide extended antigen information for patients with complex transfusion requirements. The market is forecast to reach USD 5.31 billion by 2035 from USD 2.41 billion in 2025.

Automation is becoming an important part of modern blood-bank workflows. Automated platforms can reduce manual intervention and support consistent testing processes, while molecular technologies are increasingly used when conventional serological methods cannot fully resolve complex antigen profiles. These developments are particularly relevant for patients receiving long-term transfusion support.

Services are projected to be the fastest-growing product category, with an estimated 11.1% CAGR through 2035. Molecular and next-generation sequencing approaches are also expected to expand as laboratories adopt extended genotyping. Antigen typing is forecast to grow at 12.3% CAGR, while diagnostic laboratories and other end users are expected to record 14.3% CAGR during the forecast period.

Regional development is supported by different healthcare priorities. North America benefits from established regulatory and transfusion infrastructure, Europe is adapting to evolving IVD requirements, and Asia-Pacific is expanding through government blood-safety initiatives. Point-of-care blood typing and AI-integrated image interpretation represent additional opportunities for future market development.

The Blood Group Typing Market is developing as blood banks and clinical laboratories adopt technologies that provide more standardized and detailed blood classification. Traditional serological testing remains widely used for routine ABO and Rh identification, while molecular testing is gaining relevance for extended antigen matching. The market is expected to grow at a CAGR of 8.2% from 2026 to 2035.

Rising global surgical activity is increasing the need for reliable transfusion support, while government blood-safety mandates are encouraging laboratories to modernize testing infrastructure. Automation can help address operational pressures in blood banks, and molecular genotyping provides additional information for patients with complex blood-group profiles.

Serology assay-based testing held a 53.2% share in 2025, making it the largest technique segment. ABO blood tests accounted for 37.8% of the test-type market, while consumables represented 44.3% of product demand. Hospitals led the end-user segment with 48.2% share, supported by blood-bank and transfusion testing requirements.

Asia-Pacific is expected to be a key growth region, with a projected 9.4% CAGR between 2026 and 2035. North America held 35.5% of the market in 2025, while Europe accounted for 28%. Expanding hospital networks, national blood

Strengthen your strategy with data-backed research insights:

Pain Management Market Size

Palliative Care Market Share

Palliative Care Market Trends

Palliative Care Market Growth

Neuropathic Pain Market Demand-donation programs, automated laboratories, and advanced genotyping are expected to influence future market development.